nach oben

Archives of Gynecology and Obstetrics

Erschienen in:

01.06.2014 | Gynecologic Oncology

Effects of MACC1 siRNA on biological behaviors of HeLa

verfasst von: Hongxia Chai, Yongxiu Yang

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Metastasis-associated in colon cancer 1 (MACC1) has been shown to play a critical role in several types of cancer. The purposes of this study were to evaluate MACC1 expression in cervical cancer and determine role of MACC1 small interference RNA (siRNA) in the growth and progression of cervical cancer.

Methods

Immunohistochemical analysis of MACC1 expression was performed in different cervical lesion tissues. siRNA knockdown of MACC1 was performed. Cytoskeletal staining, RT-PCR, Western blot technology, transwell migration, MTT, and flow cytometry were used for identification of the functional roles of MACC1 siRNA in HeLa cells.

Results

Immunohistochemistry demonstrated that MACC1 overexpression was detected in cervical cancer tissues. MACC1 siRNA transfection remarkably affected HeLa cell biological behaviors. Expression of MACC1 in HeLa cells was significantly down-regulated by MACC1 siRNA. In addition, knockdown of MACC1 in HeLa cells caused a significant decrease in cell proliferation or migration, and increased cell apoptosis rate. Flow cytometry showed that MACC1 siRNA may inhibit cell proliferation by interfering with cell mitosis and cell cycle progression.

Conclusions

These results suggest that MACC1 is a novel biomarker for cervical cancer diagnosis and a target for therapeutic interventions. Decreasing MACC1 expression by siRNA may prove to be an effective genetic therapy strategy.

WHO, Department of Reproductive Health WHO, Department of Chronic Diseases Health Promotion (2006) Comprehensive cervical cancer control: a guide to essential practice. WHO

Ferlay J, Shin HR, Bray F (2011) GLOBOCAN 2008: cancer incidence and mortality Worldwide: IARC CancerBase No. 10 (database on the Internet). International agency for research on cancer, Lyon

Li J, Jia H, Xie L et al (2009) Correlation of inhibitor of differentiation 1 expression to tumor progression, poor differentiation and aggressive behaviors in cervical carcinoma. Gynecol Oncol 114:89–93PubMedCrossRef

Burd EM (2003) Human papillomavirus and cervical cancer. Clin Microbiol Rev 16:1–17PubMedCentralPubMedCrossRef

Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90PubMedCrossRef

Stein U, Smith J, Walther W, Arlt F (2009) MACC1 controls Met: what a difference an Sp1 site makes. Cell Cycle 8:2467–2469PubMedCrossRef

Arlt F, Stein U (2009) Colon cancer metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem Cell Biol 41:2356–2359PubMedCrossRef

Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R et al (2011) Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet 36:40–45CrossRef

Stein U, Walther W, Arlt F, Schwabe H, Smith J, Fichtner I et al (2008) MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 15:59–67PubMed

10.

Armes JE, Trute L, White D et al (1999) Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers a population-based study. Cancer Res 59:2011–2017PubMed

11.

Bouras T, Southey MC, Venter DJ (2001) Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Cancer Res 61:903–907PubMed

12.

Birchmeier C, Birchmeier W, Gherardi E, Woude GFV (2003) Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4:915–925PubMedCrossRef

13.

Stella MC, Trusolino L, Pennacchietti S, Comoglio PM (2005) Negative feedback regulation of Met-dependent invasive growth by Notch. Mol Cell Biol 25:3982–3996PubMedCentralPubMedCrossRef

14.

Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Woude GV, Aaronson SA (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science (New York, NY) 51:802CrossRef

15.

Blumenschein GR, Mills GB, Gonzalez-Angulo AM (2012) Targeting the hepatocyte growth factor—cMET axis in cancer therapy. J Clin Oncol 30:287–3296CrossRef

16.

Toschi L, Jänne PA (2008) Single-agent and combination therapeutic strategies to inhibit hepatocyte growth factor/MET signaling in cancer. Clin Cancer Res 14:941–5946CrossRef

17.

Kokoszyńska K, Kryński J, Rychlewski L, Wyrwicz LS (2009) Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochim Pol 56:317–323PubMed

18.

Boardman LA (2009) Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer. Genome Med 1:36PubMedCentralPubMedCrossRef

19.

Yu JY, DeRuiter SL, Turner DL (2002) RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci 99:6047–6052PubMedCentralPubMedCrossRef

20.

Matsumura A, Kubota T, Taiyoh H, Fujiwara H, Okamoto K, Ichikawa D (2013) HGF regulates VEGF expression via the c-Met receptor downstream pathways, PI3K/Akt, MAPK and STAT3, in CT26 murine cells. Int J Oncol 42:535–542PubMed

Titel: Effects of MACC1 siRNA on biological behaviors of HeLa
verfasst von: Hongxia Chai
Yongxiu Yang
Publikationsdatum: 01.06.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 6/2014
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-013-3126-z

Neu im Fachgebiet Gynäkologie und Geburtshilfe

23.04.2024 | Medikamente in Schwangerschaft und Stillzeit | Nachrichten

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Effects of MACC1 siRNA on biological behaviors of HeLa

Abstract

Purpose

Methods

Results

Conclusions

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2014

Impact of an intensive follow-up program on the postpartum glucose tolerance testing rate

Medical management of early pregnancy failure (EPF): a retrospective analysis of a combined protocol of mifepristone and misoprostol used in clinical practice

Management of cesarean scar pregnancy with suction curettage: a report of four cases and review of the literature

A multicentric randomized study comparing two techniques of magnification assisted loop excision of high-grade cervical intraepithelial neoplasia: video exoscopy and colposcopy

Prophylactic mastectomy with immediate reconstruction combined with simultaneous laparoscopic salpingo-oophorectomy via a transmammary route: a novel surgical approach to female BRCA-mutation carriers

Scimitar syndrome and pregnancy, complicated with severe preeclampsia

Neu im Fachgebiet Gynäkologie und Geburtshilfe

ICI-Therapie in der Schwangerschaft wird gut toleriert

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

Harnwegsinfektprophylaxe: Es geht auch ohne Antibiotika

Update Gynäkologie